Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:51:46.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:45:36.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 and the previous funding/status notice (v3.4.1) was removed. The core study details remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T11:16:47.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:33:41.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Show glossary is now visible and the QC criteria label has been updated to 'Last Update Submitted that Met QC Criteria'. The footer now includes 'No FEAR Act Data' and a revision note 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T04:14:17.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T02:40:03.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.